AGA Medical Corporation was a prominent medical device company specializing in the design, development, manufacture, and commercialization of innovative, minimally invasive devices for treating structural heart defects and vascular diseases. Renowned for its Amplatzer® family of occluders, AGA Medical significantly advanced interventional cardiology and radiology. The company focused on providing solutions for conditions such as atrial septal defects (ASDs), patent foramen ovale (PFO), and other vascular abnormalities. AGA Medical was acquired by St. Jude Medical in 2010, which subsequently became part of Abbott in 2017.
The headquarters served as the primary center for AGA Medical's corporate leadership, research and development, manufacturing operations, and administrative functions.
The facility likely included advanced R&D laboratories, specialized cleanroom manufacturing areas for medical devices, and corporate office space tailored to support its innovative operations.
AGA Medical fostered a culture centered on innovation, engineering excellence, and a strong commitment to improving patient lives. The environment was likely collaborative and research-intensive, driven by the impact of its groundbreaking medical technologies.
The Plymouth headquarters was pivotal as the operational core where the Amplatzer devices were developed and manufactured, revolutionizing the treatment of numerous structural heart conditions worldwide.
Prior to its acquisition in 2010, AGA Medical Corporation had established a strong global footprint, with its innovative medical devices sold in over 100 countries. This extensive reach was supported by direct sales forces in major markets like the United States and parts of Europe, complemented by a wide network of independent distributors in other international territories. Globally supported functions included sales, marketing, clinical education and support, regulatory affairs, and the distribution of its specialized cardiovascular and peripheral vascular intervention products.
5050 Nathan Lane North
Plymouth
Minnesota
USA
Address: Mainzer Landstrasse 41, 60329 Frankfurt am Main, Germany (Historical Address)
To spearhead market penetration, provide localized support for AGA's cardiovascular devices, and manage logistical operations across its European and nearby markets.
Address: Historical distribution facility, specific street address not readily available.
To ensure timely and effective distribution logistics for AGA's medical devices throughout its European network.
Address: Historical operational or manufacturing site, specific street address not readily available.
To enhance manufacturing capabilities or provide specialized operational support within the United States.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, AGA Medical' leadership includes:
AGA Medical has been backed by several prominent investors over the years, including:
The most significant executive changes at AGA Medical Corporation occurred around its acquisition by St. Jude Medical, announced in October 2010 and completed in November 2010. Key executives transitioned out of their roles at AGA Medical or into new positions within the acquiring entity. No major new executive hires into AGA Medical's standalone leadership team were reported in its final months of independent operation.
Discover the tools AGA Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition, AGA Medical Corporation likely used common corporate email formats. Based on typical conventions for a company of its era and size, email addresses would have been structured using employee names and the company domain 'agamed.com'. This domain is no longer active.
[first_initial][last]@agamed.com (e.g., jdoe@agamed.com) or [first].[last]@agamed.com (e.g., jane.doe@agamed.com). Domain is inactive.
Format
fgougeon@agamed.com (example, domain inactive)
Example
0%
Success rate
Reuters • November 18, 2010
St. Jude Medical Inc said it completed its $1.3 billion acquisition of AGA Medical Holdings Inc, a maker of devices to treat structural heart defects. The deal expands St. Jude's portfolio in the cardiovascular device market....more
Medical Device and Diagnostic Industry (MD+DI) • October 19, 2010
St. Jude Medical Inc. (St. Paul, MN) has signed a definitive agreement to acquire AGA Medical Holdings Inc. (Plymouth, MN) for an estimated $1.27 billion. The deal gives St. Jude access to AGA's portfolio of minimally invasive devices for structural heart defects....more
Business Wire • March 10, 2008
AGA Medical Corporation today announced that it has received CE Mark approval to market its AMPLATZER™ Cardiac Plug (ACP) device in the European Union. The ACP is a minimally invasive, catheter-delivered device intended to prevent blood clot embolization from the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including AGA Medical, are just a search away.